Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Unknown × regorafenib × Clear all

Phase

Phase 2 16 Phase 1/2 4 Phase 1 4 Phase NA 2 Phase 3 1 Phase 2/3 1

Status

Completed 8 Active not recruiting 4 Terminated 3 Not yet recruiting 2 Withdrawn 1 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasm Metastasis 1 Carcinoma 1 Adenocarcinoma 1

Interventions

Cisplatin 116 Radiotherapy 88 Carboplatin 71 Paclitaxel 69 Cyclophosphamide 69 Fluorouracil 67 Gemcitabine 60 Docetaxel 60 Capecitabine 59 Oxaliplatin 55 Etoposide 53 Doxorubicin 50 Vincristine 41 Leucovorin 39 Cytarabine 35 Chemotherapy, Adjuvant 35 Dexamethasone 30 Drug Therapy 29 Epirubicin 25 Bevacizumab 23 Pemetrexed 22 Tamoxifen 21 Prednisone 21 Irinotecan 21 Neoadjuvant Therapy 19 Methotrexate 19 Rituximab 18 Radiotherapy, Intensity-Modulated 18 Melphalan 18 apatinib 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02773524 2022-01-13

INTEGRATEIIa

Australasian Gastro-Intestinal Trials Group

Phase 3 Unknown

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡